[ Price : $8.95]
FDA approves Genentechs Avastin (bevacizumab), either in combination with carboplatin and paclitaxel or in combination with carbop...[ Price : $8.95]
Federal Register Notice: FDA extends the comment period related to its public meeting on Pre-Market Evaluation of Abuse-Deterrent ...[ Price : $8.95]
After almost 25 years at FDA, CDER Office on New Drugs director John Jenkins announces his retirement.[ Price : $8.95]
Federal Register Notice: FDA seeks comments on an information collection extension request related to a guidance on Providing Info...[ Price : $8.95]
Federal Register Notice: FDA makes available a guidance entitled Clinical Pharmacology Section of Labeling for Human Prescription ...[ Price : $8.95]
Kyocera Medical Corp. receives 510(k) clearance for its Initia Total Hip System which features Bioceram Azul (blue) zirconia-tough...[ Price : $8.95]
Kite Pharma begins a rolling BLA submission for KTE-C19 (axicabtagene ciloleucel) as a treatment for patients with relapsed/refrac...[ Price : $8.95]
FDA posts a transcript of its 11/2 public meeting on Medical Device User Fee Amendments that discussed proposed recommendations fo...